A UGT1A1 Genotype-Directed Study of Belinostat Pharmacokinetics and Toxicity
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
Instituto do Cancer do Estado de São Paulo
National Institutes of Health Clinical Center (CC)
Fundación de investigación HM
Rezolute
RayzeBio, Inc.
National Health Research Institutes, Taiwan
National Institutes of Health Clinical Center (CC)
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Turning Point Therapeutics, Inc.
National Institutes of Health Clinical Center (CC)
Ipsen
RayzeBio, Inc.
Boston Scientific Corporation
National Institutes of Health Clinical Center (CC)
Centre Hospitalier Universitaire Dijon
Exelixis
Methodist Health System
University of Wisconsin, Madison
Centre Oscar Lambret
Stanford University
University of California, San Francisco
Huazhong University of Science and Technology
Crinetics Pharmaceuticals Inc.
Crinetics Pharmaceuticals Inc.
Grupo Espanol de Tumores Neuroendocrinos
Children's Oncology Group
National Institutes of Health Clinical Center (CC)
Cedars-Sinai Medical Center
Tata Memorial Hospital
University of Utah
University of Alberta
Institut du Cancer de Montpellier - Val d'Aurelle
Institut du Cancer de Montpellier - Val d'Aurelle
Chimeric Therapeutics
SAPU NANO (US) LLC
Barbara Ann Karmanos Cancer Institute
University of Nebraska
Guerbet
IRCCS San Raffaele
Mayo Clinic
University Hospital, Strasbourg, France
Shanghai Zhongshan Hospital
ITM Solucin GmbH
University of Miami
Washington University School of Medicine
Tanabe Pharma America, Inc.
Abramson Cancer Center at Penn Medicine
Nantes University Hospital
Fox Chase Cancer Center